Find a Professional

Find a Professional

340B Policy Analysis

Our professionals routinely advise trade organizations and manufacturers on the impact health policy has on the 340B channel.

BRG’s Washington, DC–based team has its finger on the pulse of today’s policymakers. Our professionals routinely advise trade organizations and manufacturers on the impact health policy has on the 340B channel. Our team can help you understand the policy implications for your business, whether it is legislation that directly impacts the 340B program or regulations that may have a secondary effect on the channel.

Navigating a Complex Ecosystem

The 340B program is a complex and interconnected ecosystem of patients, payers, providers, pharmacies, PBMs, and manufacturers. Changes in one part of this ecosystem can have unintended consequences, and these changes can stem from state and federal legislation, regulation, and court rulings. Predicting how the ecosystem will react enables manufacturers to avoid the many pitfalls inherent to policy change in the healthcare industry.

How BRG Can Help

BRG brings together a unique combination of seasoned consultants, former industry executives, and Washington insiders with extensive experience analyzing health policy. We are positioned to help our clients anticipate the direction of health policy and understand the implications for their business.

  • John Kelliher, former chief counsel of US House Committee on Ways and Means
  • Ed Buthusiem, former pharmaceutical manufacturer executive
  • Jim Teisl, former principal analyst at Medicaid and CHIP Payment and Access Commission
  • Mara Mitchel, former PBM executive
  • Misha Segal, former director of Policy and Data Analytics at CMS
  • Aaron Vandervelde, healthcare policy and 340B expert

Unsure how the latest news will impact you? BRG can help: 340BSolutions@thinkbrg.com